A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. [electronic resource]
Producer: 20090402Description: 619-24 p. digitalISSN:- 1879-0828
- Amikacin -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Anti-Infective Agents -- administration & dosage
- Bacterial Infections -- drug therapy
- Ceftazidime -- administration & dosage
- Ceftriaxone -- administration & dosage
- Ciprofloxacin -- administration & dosage
- Cost-Benefit Analysis
- Drug Costs
- Drug Therapy, Combination
- Female
- Fever -- etiology
- Greece
- Humans
- Male
- Middle Aged
- Neutropenia -- complications
- Prospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.